{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:18:33Z","timestamp":1787181513039,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001663","name":"Volkswagen Foundation","doi-asserted-by":"publisher","award":["01FP14030E"],"award-info":[{"award-number":["01FP14030E"]}],"id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jhin.2023.10.016","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T22:11:06Z","timestamp":1699308666000},"page":"160-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Drug monitoring during ciprofloxacin prophylaxis of allogeneic stem cell transplant patients: associations with bacterial infections through a monocentric observational prospective study"],"prefix":"10.1016","volume":"143","author":[{"given":"H.E.J.","family":"Kaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hasenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Streit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Eiffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Truemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kaase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Scheithauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2023.10.016_bib1","series-title":"Infections in allogeneic stem cell transplantation. Principles and practice of transplant infectious diseases","first-page":"209","author":"Pereira","year":"2018"},{"key":"10.1016\/j.jhin.2023.10.016_bib2","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2023.10.016_bib3","series-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","author":"Carreras","year":"2019"},{"key":"10.1016\/j.jhin.2023.10.016_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10096-005-1278-x","article-title":"Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia","volume":"24","author":"Kern","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2023.10.016_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/1471-2334-13-356","article-title":"Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance","volume":"13","author":"Garnica","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhin.2023.10.016_bib6","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3324\/haematol.2016.147934","article-title":"Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center","volume":"101","author":"Pohlen","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jhin.2023.10.016_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/cid\/ciab1000","article-title":"Cessation of ciprofloxacin prophylaxis in haemato-oncology patients","volume":"75","author":"Caldwell","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2023.10.016_bib8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcrc.2007.11.011","article-title":"Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study","volume":"23","author":"van Zanten","year":"2008","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jhin.2023.10.016_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijantimicag.2008.05.019","article-title":"Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches","volume":"32","author":"Conil","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2023.10.016_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106572","article-title":"Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients","volume":"59","author":"Wicha","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2023.10.016_bib11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00134-017-4780-6","article-title":"The role of infection models and PK\/PD modelling for optimising care of critically ill patients with severe infections","volume":"43","author":"T\u00e4ngd\u00e9n","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhin.2023.10.016_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.2011.04080.x","article-title":"Therapeutic drug monitoring of antimicrobials","volume":"73","author":"Roberts","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jhin.2023.10.016_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-1-62703-050-2_16","article-title":"Non-compartmental analysis","volume":"929","author":"Gabrielsson","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhin.2023.10.016_bib14","series-title":"Pharmacokinetic and pharmacodynamic data analysis \u2013 concepts and applications","author":"Gabrielsson","year":"2016"},{"key":"10.1016\/j.jhin.2023.10.016_bib15","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1128\/AAC.01131-16","article-title":"Bayesian estimation of tobramycin exposure in patients with cystic fibrosis","volume":"60","author":"Barras","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2023.10.016_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13054-020-2753-6","article-title":"Lactate kinetics in ICU patients using a bolus of 13C-labeled lactate","volume":"24","author":"Grip","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jhin.2023.10.016_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","article-title":"Survival analysis part I: basic concepts and first analyses","volume":"89","author":"Clark","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhin.2023.10.016_bib18","first-page":"13","article-title":"Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials","volume":"69","author":"Kimura","year":"2014","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jhin.2023.10.016_bib19","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2023.10.016_bib20","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/s41409-020-0923-4","article-title":"Ciprofloxacin prophylaxis is associated with a lower incidence of Gram-negative bacteremia in patients undergoing allogeneic hematopoietic cell transplantation","volume":"55","author":"Maurer","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jhin.2023.10.016_bib21","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00228-020-02873-5","article-title":"Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients","volume":"76","author":"Abdulla","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jhin.2023.10.016_bib22","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3390\/pharmaceutics13081156","article-title":"No time dependence of ciprofloxacin pharmacokinetics in critically ill adults: comparison of individual and population analyses","volume":"13","author":"\u0160\u00edma","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jhin.2023.10.016_bib23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/0091270004266843","article-title":"Sex-related differences in the pharmacokinetics of oral ciprofloxacin","volume":"44","author":"Overholser","year":"2004","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jhin.2023.10.016_bib24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","article-title":"Pharmacodynamics of intravenous ciprofloxacin in\u00a0seriously ill patients","volume":"37","author":"Forrest","year":"1993","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670123003511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670123003511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:24:25Z","timestamp":1759292665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670123003511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":24,"alternative-id":["S0195670123003511"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2023.10.016","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug monitoring during ciprofloxacin prophylaxis of allogeneic stem cell transplant patients: associations with bacterial infections through a monocentric observational prospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2023.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}